Early breast cancer is often treated with curative intent—but there is still more to learn about treatment response and recurrence risk. Explore how researchers are following the science earlier in the disease journey to address unmet needs and advance new possibilities for patients.

Behind every medicine is a story—a story of people who make it possible. In the series Where Craft Meets, Daiichi Sankyo explores and celebrates the people behind our medicines and shares how our unique crafts contribute to our collective mission to help patients.

Cancer care is never carried out by one person alone. It is a team effort, with oncologists, nurses, pharmacists, pathologists, patient support teams, caregivers, and many others all supporting the patient.

I had no idea what to expect when I was deployed to Ground Zero. In moments like that, you do not hesitate, you jump into action. You do everything you can to help reconnect families.

Working at Daiichi Sankyo, cancer was part of my everyday life. But this was different. This was my dad, and it was a diagnosis I knew would not end with the ringing of a bell…

In certain cancers, HER2 becomes overexpressed or uncontrolled, driving tumors to develop quickly. As our understanding of HER2 and its role deepens, its relevance across endometrial, ovarian and other gynecologic tumors has become…